Pre-treatment of allogeneic bone marrow recipients with the CXCR4 antagonist AMD3100 transiently enhances hematopoietic chimerism without promoting donor-specific skin allograft tolerance

Published 2015 View Full Article

Authors

Keywords

AMD3100, CXCR4, Bone marrow mobilization, Mixed chimerism, Tolerance

Journal

TRANSPLANT IMMUNOLOGY

Volume 33, Issue 2, Pages 125-129

Publisher

Elsevier BV

Online

2015-07-21

DOI

10.1016/j.trim.2015.07.003

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now